From Financial Modeling Prep: 2024-10-14 07:00:01

In summary, Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is facing challenges in the retail pharmacy industry, with weak consumer behavior and competitive pressures impacting its stock performance. Analysts have revised their price targets downward, reflecting a more cautious outlook for the company. Despite projected revenue of $34.9 billion and earnings of $0.38 per share for fiscal Q4 2024, concerns about earnings expectations and a lack of catalysts for a turnaround have led to a decline in the stock’s value. Investors should be mindful of these factors when considering WBA as an investment option.



Read more at Financial Modeling Prep:: Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Faces…